Perrigo (PRGO) Total Current Liabilities (2013 - 2026)

Perrigo's (PRGO) quarterly Total Current Liabilities came in at $997.6 million in Q1 2026, down 7.1% year-on-year from $1.1 billion in Q1 2025, and down 1.51% on a QoQ basis from $1.0 billion in Q4 2025.

Perrigo (PRGO) Total Current Liabilities (2013 - 2026) Analysis & Trends

Perrigo (PRGO) has 14 years of Total Current Liabilities data on file, last reported at $997.6 million in Q1 2026.

  • On a quarterly basis, Total Current Liabilities fell 7.1% year-over-year to $997.6 million in Q1 2026; TTM through Mar 2026 was $997.6 million, a 7.1% decrease from a year earlier, with the FY2025 full-year figure at $1.0 billion, down 3.0% from the prior year.
  • Total Current Liabilities for Q1 2026 stood at $997.6 million, down from $1.0 billion in the prior quarter.
  • Over the last five years, Total Current Liabilities for PRGO reached as high as $1.6 billion in Q4 2023 and fell as low as $981.3 million in Q2 2022.
  • Historically, Total Current Liabilities has averaged $1.2 billion across 5 years, with a median of $1.1 billion in 2025.
  • Across the five-year window, Total Current Liabilities tumbled 49.35% in 2022 and soared 43.84% in 2024, its largest moves.
  • Year by year, Total Current Liabilities stood at $1.1 billion in 2022, then soared by 42.45% to $1.6 billion in 2023, then sank by 34.17% to $1.0 billion in 2024, then slipped by 3.0% to $1.0 billion in 2025, then declined by 1.51% to $997.6 million in 2026.
  • Per Business Quant data, the three most recent Total Current Liabilities figures were $997.6 million in Q1 2026, $1.0 billion in Q4 2025, and $1.1 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 6.56 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 13.53 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 2.05 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 18.06 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 599.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 13.17 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 6.81 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 831.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 1.66 Bn
10 Perrigo 1.40 Bn 1.05 Bn 325.50 Mn 997.60 Mn

Historic Data

Download Data
DateValue
Mar 28, 2026 997.60 Mn
Dec 31, 2025 1.01 Bn
Sep 27, 2025 1.15 Bn
Jun 28, 2025 1.13 Bn
Mar 29, 2025 1.07 Bn
Dec 31, 2024 1.04 Bn
Sep 28, 2024 1.45 Bn
Jun 29, 2024 1.49 Bn
Mar 30, 2024 1.55 Bn
Dec 31, 2023 1.59 Bn
Sep 30, 2023 1.01 Bn
Jul 1, 2023 1.06 Bn
Apr 1, 2023 1.09 Bn
Dec 31, 2022 1.11 Bn
Oct 1, 2022 1.02 Bn
Jul 2, 2022 1.01 Bn
Apr 2, 2022 981.30 Mn
Dec 31, 2021 1.59 Bn
Oct 2, 2021 2.00 Bn
Jul 3, 2021 1.98 Bn